Drugs / AJM347
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03133468 | Jul 2017 → Jul 2018 | — | EA Pharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AJM347 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03133468 ↗ |
| Route | Oral | “Oral administration” NCT03133468 ↗ |